Dr. Michael Thirman, MD

Claim this profile

University of Chicago Comprehensive Cancer Center

Studies Chronic Lymphocytic Leukemia
Studies Lymphoma
3 reported clinical trials
5 drugs studied

Area of expertise

1

Chronic Lymphocytic Leukemia

Michael Thirman, MD has run 3 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:

13q positive
13q negative
12 positive
2

Lymphoma

Michael Thirman, MD has run 2 trials for Lymphoma. Some of their research focus areas include:

13q positive
13q negative
12 positive

Affiliated Hospitals

Image of trial facility.

University Of Chicago Comprehensive Cancer Center

Image of trial facility.

UC Comprehensive Cancer Center At Silver Cross

Clinical Trials Michael Thirman, MD is currently running

More about Michael Thirman, MD

Clinical Trial Related

6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Michael Thirman, MD has experience with

  • Obinutuzumab
  • Venetoclax
  • Pembrolizumab
  • TGR-1202
  • Ibrutinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Michael Thirman, MD specialize in?

Is Michael Thirman, MD currently recruiting for clinical trials?

Are there any treatments that Michael Thirman, MD has studied deeply?

What is the best way to schedule an appointment with Michael Thirman, MD?

What is the office address of Michael Thirman, MD?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security